New pill shows promise for Long-Term psoriatic arthritis control
NCT ID NCT07286058
First seen Jan 10, 2026 · Last updated May 18, 2026 · Updated 24 times
Summary
This study looks at the long-term safety and effectiveness of the drug zasocitinib for adults with psoriatic arthritis, a condition causing joint pain and skin problems. About 1,182 people who completed a one-year study on this drug can join and take it daily for up to two more years. The goal is to see if the drug remains safe and helps control symptoms over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First OC Dermatology Research Inc.
RECRUITINGFountain Valley, California, 92708, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.